World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 12 December 2020
Main ID:  NCT01170234
Date of registration: 23/07/2010
Prospective Registration: Yes
Primary sponsor: Tufts Medical Center
Public title: Exhaled Nitric Oxide as a Biomarker of Disease Activity in Eosinophilic Esophagitis
Scientific title: Exhaled Nitric Oxide as a Biomarker of Disease Activity in Eosinophilic Esophagitis
Date of first enrolment: August 2010
Target sample size: 14
Recruitment status: Completed
URL:  https://clinicaltrials.gov/show/NCT01170234
Study type:  Observational
Study design:   
Phase: 
Countries of recruitment
United States
Contacts
Name:     John Leung, MD
Address: 
Telephone:
Email:
Affiliation:  Tufts Medical Center
Key inclusion & exclusion criteria

Inclusion Criteria:

- Age 7-65.

- Confirmed diagnosis of EoE. The diagnosis of eosinophilic esophagitis is based upon
the presence of characteristic clinical features and large numbers of eosinophils in
the esophagus on pathologic examination (=15 eosinophils per high powered [400x] field
in at least one specimen) despite acid suppression with a PPI for one to two months.
The criteria also include normal gastric and duodenal mucosal biopsies and the
exclusion of other causes. Clinical features in adults include dysphagia, pain and/or
history of food impaction. Symptoms in children vary depending in part upon their age:
feeding disorders (median age 2.0), vomiting (median age 8.1), abdominal pain (median
age 12.0), dysphagia (median age 13.4), and food impaction (median age 16.8).

Exclusion Criteria:

- Use of systemic or inhaled corticosteroids in the preceding 3 months.

- History of doctor-diagnosed asthma, acute or chronic rhinosinusitis.

- History of cirrhosis.

- History of kidney, heart or lung disease.

- Pregnancy



Age minimum: 7 Years
Age maximum: 65 Years
Gender: All
Health Condition(s) or Problem(s) studied
Eosinophilic Esophagitis
Intervention(s)
Device: NIOX MINO® Airway Inflammation Monitor
Primary Outcome(s)
Exhaled nitric oxide as a biomarker for disease activity in eosinophilic esophagitis [Time Frame: 2 years]
Secondary Outcome(s)
Exhaled nitric oxide as a biomarker for disease activity in eosinophilic esophagitis [Time Frame: 2 years]
Secondary ID(s)
TUFTS-EOE-FENO
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history